FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pharmacology and pharmacy and concerns production of an antiglycating agent. Such agent is a pharmaceutical composition in a solid dosage form for oral administration, containing as an active ingredient sodium salt of diethyl ether 4-oxo-1,4-dihydropyrazolo[5,1-c]-1,2,4-triazin-3,8 -dicarboxylic acid monohydrate, with the following ratio of components, wt. %: sodium salt of diethyl ether of 4-oxo-1,4-dihydropyrazolo[5,1-c]-1,2,4-triazine-3,8-dicarboxylic acid monohydrate 95–97.0 %; Plasdone K-29/32 1–5 %; magnesium stearate not more than 1 %.
EFFECT: composition provides an antiglycating effect by inhibiting effect on end glycation products of collagen.
3 cl, 7 dwg, 2 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| SODIUM SALT OF DIETHYL ETHER OF 4-OXO-1,4-DIHYDROPYRAZOLO[5,1-C]-1,2,4-TRIAZINE-3,8-DICARBOXYLIC ACID MONOHYDRATE | 2015 |  | RU2612300C1 | 
| SODIUM SALT OF 3-NITRO-4-OXO-1,4-DIHYDROPYRAZOLO[5,1-c]-1,2,4-TRIAZINE-8-CARBOXYLIC ACID, DIHYDRATE | 2016 | 
 | RU2641107C1 | 
| USE OF SODIUM SALT OF DIETHYL ESTER OF 4-OXO-1,4-DIHYDROPYRAZOLO[5,1-C]-1,2,4-TRIAZINE-3,8-DICARBOXYLIC ACID, MONOHYDRATE AS DRUG FOR TREATMENT AND PREVENTION OF LATE COMPLICATIONS OF DIABETES MELLITUS | 2019 | 
 | RU2765117C2 | 
| 2-(5-NITRONYLFURAN-2-YL)-5-METHYL-6-NITRO-1,2,4-TRIAZOLO[1,5-A]PYRIMIDIN-7(4N)-ONE AND SALTS THEREOF | 2018 | 
 | RU2716715C2 | 
| METHOD OF PRODUCING HIGHLY CONCENTRATED SOLUTION OF RIAMILOVIR | 2024 | 
 | RU2830367C1 | 
| 3-GUANIDINOAZOLO[1,2,4,5]TETRAZINES HAVING ANTIGLYCATING ACTIVITY AND A PROCESS FOR THEIR PREPARATION | 2017 | 
 | RU2668971C1 | 
| SODIUM SALT OF 2-METHYLTHIO-6-CYANO-1,2,4-TRIAZOLO[5,1-C]-1,2,4-TRIAZIN-7(4H)-ONE, TRIHYDRATE | 2015 | 
 | RU2607628C1 | 
| BIS[1,2,4]TRIAZOLO[4,3-b:3',4'-f][1,2,4,5]TETRAZINES WITH ANTI-GLYCATING, ANTI-GLYCOXIDATION AND ANTIPLATELET ACTIVITY | 2020 | 
 | RU2755897C1 | 
| ETHYL ESTER OF 2-(ADAMANTAN-1-yl)-3-BROMO-7-OXO-4,7-DIHYDROPYRAZOLO[1,5-a]PYRIMIDINE-6-CARBOXYLIC ACID, HAVING ANTIVIRAL ACTION ON SARS-CoV-2 CORONAVIRUS | 2024 | 
 | RU2839407C1 | 
| 2-METHYLTHIO-6-NITRO-1,2,4-TRIAZOLO[5,1-C]-1,2,4-TRIAZINE-7(4H)-ONE SODIUM SALT DIHYDRATE POSSESSING ANTIVIRAL ACTIVITY | 2005 | 
 | RU2294936C1 | 
Authors
Dates
2020-12-17—Published
2019-07-15—Filed